» Articles » PMID: 28655520

The Mitochondrial Dynamics in Cancer and Immune-surveillance

Overview
Specialty Oncology
Date 2017 Jun 29
PMID 28655520
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria-shaping proteins control the dynamic equilibrium between fusion and fission of the mitochondrial network. Their balance is strictly required to regulate various processes, including the quality of mitochondria, cell metabolism, cell death, proliferation and cell migration. Alterations in these processes are frequently encountered in cancer, during both its onset and later progression, as evidence emerge connecting alterations in mitochondrial dynamics with cancer development. In recent years, novel therapeutic approaches to fight against different human tumors aim at exploiting the immune system's ability to specifically recognize tumor antigens, thus killing malignant cells in a process named immune-surveillance. Interestingly, data are accumulating on the role that mitochondrial dynamics play also for the correct function of both the innate and the adaptive immune system. By this review, we overview how mitochondrial dynamics can affect various processes during cancer development, acting directly on tumor cells or indirectly on cells responsible for tumor aggression and defence.

Citing Articles

PINCH-1 promotes tumor growth and metastasis by enhancing DRP1-mediated mitochondrial fission in head and neck squamous cell carcinoma.

Tian R, Song H, Li J, Yuan T, Liu J, Wang Y Cancer Biol Ther. 2025; 26(1):2477365.

PMID: 40065703 PMC: 11901378. DOI: 10.1080/15384047.2025.2477365.


Impact of mitochondrial dysfunction on the antitumor effects of immune cells.

Wang Q, Yin X, Huang X, Zhang L, Lu H Front Immunol. 2024; 15:1428596.

PMID: 39464876 PMC: 11502362. DOI: 10.3389/fimmu.2024.1428596.


The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy.

Chen F, Xue Y, Zhang W, Zhou H, Zhou Z, Chen T Cancer Metastasis Rev. 2024; 43(4):1419-1443.

PMID: 39307891 PMC: 11554835. DOI: 10.1007/s10555-024-10211-9.


Extracellular Vesicles & Co.: scaring immune cells in the TME since ever.

Rodolfo C, Campello S Front Immunol. 2024; 15:1451003.

PMID: 39267748 PMC: 11390669. DOI: 10.3389/fimmu.2024.1451003.


Identifying prognostic biomarkers in oral squamous cell carcinoma: an integrated single-cell and bulk RNA sequencing study on mitophagy-related genes.

Li M, Wei Y, Huang W, Wang C, He S, Bi S Sci Rep. 2024; 14(1):19992.

PMID: 39198614 PMC: 11358153. DOI: 10.1038/s41598-024-70498-0.